Reply

Affiliations

¹ Tokai University School of Medicine, Kanagawa, Japan.
² Tokai University School of Medicine, Kanagawa, Japan. Electronic address: ko-asano@tokai-u.jp.

Comment

Tsuyoshi Oguma et al. J Allergy Clin Immunol. 2021 Mar.

. 2021 Mar;147(3):1121.

doi: 10.1016/j.jaci.2020.11.030. Epub 2021 Jan 5.

¹ Tokai University School of Medicine, Kanagawa, Japan.
² Tokai University School of Medicine, Kanagawa, Japan. Electronic address: ko-asano@tokai-u.jp.

No abstract available

Comment on

New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation.
Asano K, Hebisawa A, Ishiguro T, Takayanagi N, Nakamura Y, Suzuki J, Okada N, Tanaka J, Fukutomi Y, Ueki S, Fukunaga K, Konno S, Matsuse H, Kamei K, Taniguchi M, Shimoda T, Oguma T; Japan ABPM Research Program. Asano K, et al. J Allergy Clin Immunol. 2021 Apr;147(4):1261-1268.e5. doi: 10.1016/j.jaci.2020.08.029. Epub 2020 Sep 10. J Allergy Clin Immunol. 2021. PMID: 32920094
Is the "probable" category required in the diagnosis of ABPA?
Muthu V, Agarwal R. Muthu V, et al. J Allergy Clin Immunol. 2021 Mar;147(3):1119-1121. doi: 10.1016/j.jaci.2020.11.029. Epub 2021 Jan 5. J Allergy Clin Immunol. 2021. PMID: 33419605 No abstract available.